Detalhe da pesquisa
1.
Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.
Tumour Biol
; 39(6): 1010428317705509, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28621236
2.
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial.
Ann Oncol
; 26(8): 1722-8, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25957330
3.
First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.
Br J Cancer
; 111(2): 241-8, 2014 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24946000
4.
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Biomed Pharmacother
; 159: 114272, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36706629
5.
Association of Circulating Tumor Cells and Tumor Molecular Profile With Clinical Outcomes in Patients With Previously Untreated Metastatic Colorectal Cancer: A Pooled Analysis of the Phase III VISNÚ-1 and Phase II VISNÚ-2 Randomized Trials.
Clin Colorectal Cancer
; 22(2): 222-230, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36944559
6.
Phase II open-label study of erlotinib in combination with gemcitabine in unresectable and/or metastatic adenocarcinoma of the pancreas: relationship between skin rash and survival (Pantar study).
Ann Oncol
; 23(7): 1919-25, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22156621
7.
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines.
Clin Transl Oncol
; 24(3): 483-494, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34773566
8.
Controversies in the treatment of RAS wild-type metastatic colorectal cancer.
Clin Transl Oncol
; 23(4): 827-839, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32789773
9.
MUC4 is overexpressed in idiopathic pulmonary fibrosis and collaborates with transforming growth factor ß inducing fibrotic responses.
Mucosal Immunol
; 14(2): 377-388, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32887938
10.
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
ESMO Open
; 6(2): 100048, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33556897
11.
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
ESMO Open
; 6(2): 100062, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33711671
12.
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.
Br J Cancer
; 102(10): 1468-73, 2010 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-20424611
13.
[Self-evaluation of a clinical pathway to improve the results of rectal cancer]. / Autoevaluación de una vía clínica para mejora del proceso quirúrgico carcinoma de recto.
Cir Esp
; 87(4): 231-8, 2010 Apr.
Artigo
Espanhol
| MEDLINE | ID: mdl-20206342
14.
Analysis of the elderly patient population in a tertiary-care university hospital.
Eur J Cancer Care (Engl)
; 18(3): 264-70, 2009 May.
Artigo
Inglês
| MEDLINE | ID: mdl-19175669
15.
First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.
Eur J Cancer
; 101: 263-272, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30054049
16.
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines
Clin. transl. oncol. (Print)
; 24(3): 483-494, marzo 2022. ilus
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-203543
17.
Controversies in the treatment of RAS wild-type metastatic colorectal cancer
Clin. transl. oncol. (Print)
; 23(4): 827-839, abr. 2021.
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-220919
18.
SEOM Clinical Guideline of localized rectal cancer (2016).
Clin Transl Oncol
; 18(12): 1163-1171, 2016 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27905053
19.
Current controversies in the management of metastatic colorectal cancer.
Cancer Chemother Pharmacol
; 76(4): 659-77, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26113053
20.
First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours.
Eur J Cancer
; 51(11): 1371-80, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25963019